BlackRock has filed for its third Bitcoin exchange-traded fund (ETF), continuing its push into cryptocurrency investment products. Notably, the new filing does not include other popular cryptocurrencies like Solana or XRP, focusing solely on Bitcoin. This move highlights BlackRock's cautious approach to crypto assets, prioritizing Bitcoin's market dominance and regulatory clarity. Investors watching ETF approvals may see this as a sign of growing mainstream acceptance of Bitcoin.
BlackRock's new Bitcoin ETF filing offers context for cryptocurrency interest; here is Pluang's market snapshot as of Oct 20, 2026 15:21 WIB: Among 50 major cryptocurrencies, 18 rose and 31 fell today. LINK priced at Rp215.503 saw a slight decline of -1.90% with a near-even buy-sell split, while GRT at Rp424 and VET at Rp121 both dropped -1.75%, but VET had a notably longer typical hold time of 148 days compared to GRT's 99 days and LINK's 63 days.
VINCI's subsidiary Cobra IS secured a €165 million contract to construct a cooling plant for a major data center campus in the Iberian Peninsula. The project involves installing mechanical, electrical, and plumbing systems for 126 dry coolers, which ...
VINCI's subsidiary Cobra IS secured a €165 million contract to build the cooling system for a massive data center campus in the Iberian Peninsula. The project includes installing mechanical, electrical, and plumbing equipment for 126 air cooling unit...
Basilea Pharmaceutica announced new clinical and activity data for its antifungal drugs fosmanogepix and isavuconazole, as well as the antibiotic ceftobiprole, to be presented at IDWeek 2026 in Washington D.C. Highlights include pediatric data from f...
Gainsight introduced its AI-native services business, Atlas, which manages over $75 million in annual recurring revenue (ARR) by handling long-tail customer renewals with AI agents and human managers. The company also announced a shift to value-based...
Traders poured $54.6 million into the Direxion Daily S&P Biotech Bull 3X ETF (LABU) on October 14, 2026, marking the largest inflow relative to its $597 million size. LABU offers triple daily exposure to biotech stocks, making it highly volatile and ...
